Norman Broadbent plc
("Norman Broadbent" or the "Company")
Surrender of existing options
and
Grant of new options
Surrender of existing options
Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces that, on 6 October 2023, Peter Searle, Non-Executive Chair, surrendered for no consideration 1.0 million options over the Company's ordinary shares of 1p each ("Ordinary Shares") which were granted pursuant to the Company's Long Term Incentive Scheme ("LTIP") on 18 March 2022, Kevin Davidson, Chief Executive Officer, surrendered for no consideration 2,548,148 options over Ordinary Shares which were granted pursuant to the LTIP between 18 March 2022 and 28 July 2023, Mehr Malik, Chief Financial Officer, surrendered for no consideration 1.7 million options over Ordinary Shares which were granted pursuant to the LTIP on 28 July 2023, and Sean Bergin, who is a Person Discharging Managerial Responsibilities ("PDMR") surrendered for no consideration 1.7 million options over Ordinary Shares which were granted pursuant to the LTIP between 18 March 2022 and 28 July 2023.
The above surrenders of existing options have been made to amend the terms of the LTIP, to standardise the terms for all participants and to align the terms of the LTIP with the Board's expectations.
Grant of new options
Subsequently, each of Peter Searle, Kevin Davidson, Mehr Malik and Sean Bergin has, in accordance with the LTIP established by resolution of the Board of Directors on 6 October 2023, been granted on 6 October 2023 (the "Date of Grant ") options over Ordinary Shares exercisable at nil pence per Ordinary Share ("Options"). The following table sets out details of the Options that have been granted to both the Company's Executive Directors and one PDMR:
|
Name of Individual |
Director/PDMR |
Number of Share Price Vesting Options granted |
Number of EBITDA Vesting Options granted |
Total Number of Options granted | Percentage of the Company's Existing Issued Shares Under Option held | Percentage of the Company's Fully Diluted Share Capital held* |
| Kevin Davidson | CEO | 1,274,074 | 1,274,074 | 2,548,148 | 4.1% | 3.4% |
| Mehr Malik | CFO | 850,000 | 850,000 | 1,700,000 | 2.8% | 2.3% |
| Sean Bergin | COO and PDMR | 850,000 | 850,000 | 1,700,000 | 2.8% | 2.3% |
| Peter Searle | Non-Executive Chair | 500,000 | 500,000 | 1,000,000 | 1.6% | 1.4% |
| Total |
| 3,474,074 | 3,474,074 | 6,948,148 | 11.3% | 9.4% |
*assuming that no further Ordinary Shares are issued between the date of this announcement and exercise of the Options.
25 per cent. of the Options vest immediately on the Date of Grant and the remaining options are granted over a period of three years and vest subject to two sets of performance criteria:
· 50 per cent. of the vested Options are exercisable on a scaled basis following the price of an Ordinary Share achieving an average of between 10p and 19p over any three-month period prior to 30 June 2026 ("Share Price Vesting Options"); and
· The remaining 50 per cent. of the vested Options are exercisable on a scaled basis following the achievement by the Company of audited EBITDA in the range of greater than £0.5 million to £1.25 million in any financial year from the Date of Grant to 31 December 2025 ("EBITDA Vesting Options").
Following the grant of the Options, there are 12,148,148 options over Ordinary Shares outstanding representing 19.7 per cent. of the Company's issued share capital. At the date of this announcement, the Company has 61,817,543 Ordinary Shares in issue.
The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation is appended further below.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||
| a) | Name |
| ||||||||||||
| 2 | Reason for the notification | |||||||||||||
| a) | Position/status | See 1a) above | ||||||||||||
| b)
| Initial notification /Amendment | Initial notification | ||||||||||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||
| a) | Name | Norman Broadbent Plc | ||||||||||||
| b) | LEI | 213800E5YN5TA934XA23 | ||||||||||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||
| a)
| Description of the financial instrument, type of instrument Identification code | Options over ordinary shares of £0.01 each in Norman Broadbent Plc Identification code (ISIN) for Norman Broadbent Plc ordinary shares: GB00B3VF4Y66 | ||||||||||||
| b) | Nature of the transaction | Grant of options | ||||||||||||
| c) | Price(s) and volume(s) |
| ||||||||||||
| d) | Aggregated information - Aggregated volume - Price | N/A | ||||||||||||
| e) | Date of the transactions | Options put in place as of 06 October 2023 | ||||||||||||
| f) | Place of the transaction | Outside a trading venue | ||||||||||||
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For further information, please contact:
Norman Broadbent plc +44 (0) 20 7484 0000
Kevin Davidson, CEO
Mehr Malik, CFO
Shore Capital (Nominated Adviser and Broker) 020 7408 4090
Tom Griffiths / Tom Knibbs (Corporate Advisory)
Henry Willcocks (Corporate Broking)
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
